NIT
PRTK

NumerixS Investment Technologies’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

NumerixS Investment Technologies’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,000
Closed -$28K – 1459
2018
Q3 		$28K Buy
+3,000
New +$30.3K 0.01% 1055
2018
Q1 		– Sell
-3,800
Closed -$68K – 1328
2017
Q4 		$68K Buy
3,800
+3,300
+660% +$68.9K 0.02% 796
2017
Q3 		$13K Buy
+500
New +$11.6K ﹤0.01% 1077

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

NumerixS Investment Technologies's PRTK Position: Q4 2018 in Review

NumerixS Investment Technologies sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2018, closing a stake of 3,000 shares — an estimated $28K sold.

NumerixS Investment Technologies first reported a position in PRTK in Q3 2017 and held it in 3 quarters. The position peaked at $68K in Q4 2017. 102 funds tracked by Wall St. Rank hold PRTK as of Q4 2018.

  • NumerixS Investment Technologies reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,000 Paratek Pharmaceuticals, Inc. shares in Q4 2018, an estimated $28K.
  • NumerixS Investment Technologies first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2017 and held it in 3 quarters.
  • NumerixS Investment Technologies's Paratek Pharmaceuticals, Inc. position peaked at $68K in Q4 2017.
  • 102 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2018.

Based on NumerixS Investment Technologies's 13F filing for Q4 2018, filed 12 Feb 2019.